Similarly, in the MYCN-non-amplified primary human neuroblastoma cell line hNB, treatment with JVG045 up to 20 μM had no significant effect (F (5, 9)=1.649, p = 0.2421). This evidence concerns the gene MYCN and neuroblastoma.